A-2020-000246

Request: All communication between Health Canada and Azanta, all communication between Health Canada and Chia Chia Sun, a document(s) which specifies the following information about Nimoral and Zybrestat: the name of the company responsible for each product; the cost of each drug under the Special Access Programme (SAP); the date when each product was registered as part of the SAP program. If the product is still part of the SAP program and if the product is no longer part of the SAP program, please state the year it stopped and the reason. Whether or not the product is manufactured in Canada. How many requests for the product there have been under the SAP Program? Date range from January 1, 2010 to May 19, 2020.